Requip XL

The FDA has approved Requip XL “the first and only oral once-daily non-ergot dopamine agonist for Parkinson’s disease.” REQUIP XL is indicated for the treatment of the signs and symptoms of idiopathic Parkinson’s disease, but not restless leg syndrome. detail

0 Responses to “Requip XL”


Comments are currently closed.